EU Prostate Cancer Market, Market Segmented, by Diagnostic Techniques (Digital Rectal Exam (DRE), and Prostate-Specific Antigen Test (PSA)), by Surgery (Radical Prostatectomy, Orchidectomy, and Trans Urethral Resection (TUR)), by Radiation Therapy (External Beam Radiation Therapy, and Brachytherapy), and by Chemotherapy (Docetaxe, Etoposide, Vinblastine, Carboplatin, and Vinorelbine)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138238
- Pages: 200
-
Format:
Report Overview
The EU Prostate Cancer Market size stood at around USD $16.69 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Prostate cancer is a commercially profitable indication with a high amount of diagnosis incidences. The drug treatment of prostate cancer has evolved quickly over the last few years, with the metastatic castrate-resistant prostate cancer (CRPC) situation becoming more crowded and competitive
Market Drivers
The rising incidence of prostate cancer is recognized as a major driver for the growth of the prostate cancer market during the forecast period. Some other drivers are the increasing geriatric population base, growing demand for novel drugs, and the existence of high unmet needs. Factors restraining market growth include high treatment costs and low patient compliance due to complicated treatment method
1. EU Prostate Cancer Market Overview
A. Market Size
2. EU Prostate Cancer Market Growth Drivers.
A. The rising incidence of prostate cancer
B. Increasing geriatric population base, growing demand for novel drugs, and the existence of high unmet need
3. EU Prostate Cancer Market Segmentation
A. By Diagnostic Techniques
I. Digital Rectum Exam
II. Prostate Specific Antigen Test
B. By Surgery
I. Radical Prostatectomy
II. Orchidectomy
III. Trans Urethral Resection (TUR)
C. By Radiation Therapy
I. External Beam Radiation Therapy
II. Brachytherapy
D. By Chemotherapy
I. Docetaxe
II. Etoposide
III. Vinblastine
IV. Carboplatin
V. Vinorelbine
4. EU Prostate Cancer Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Astra Zeneca, Company overview, Product & Services, Strategies & Financials
B. Glaxo Smith Kline, Company overview, Product & Services, Strategies & Financials
C. Sanofi, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
